Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Hold
3,037
0.5% 43
2025
Q4
$1.04M Hold
3,037
0.46% 43
2025
Q3
$857K Hold
3,037
0.41% 51
2025
Q2
$848K Sell
3,037
-150
-5% -$42.5K 0.43% 48
2025
Q1
$993K Hold
3,187
0.54% 43
2024
Q4
$831K Hold
3,187
0.44% 52
2024
Q3
$1.03M Sell
3,187
-20
-0.6% -$6.54K 0.54% 43
2024
Q2
$1M Sell
3,207
-49
-2% -$14.4K 0.56% 42
2024
Q1
$926K Hold
3,256
0.52% 50
2023
Q4
$938K Hold
3,256
0.57% 44
2023
Q3
$875K Hold
3,256
0.59% 44
2023
Q2
$723K Hold
3,256
0.47% 55
2023
Q1
$787K Hold
3,256
0.56% 45
2022
Q4
$855K Buy
3,256
+105
+3% +$28.1K 0.65% 44
2022
Q3
$710K Buy
3,151
+141
+5% +$34.2K 0.57% 48
2022
Q2
$732K Hold
3,010
0.55% 49
2022
Q1
$728K Hold
3,010
0.49% 57
2021
Q4
$677K Buy
+3,010
New +$635K 0.41% 64
2021
Q3
Sell
-3,010
Closed -$734K 102
2021
Q2
$734K Hold
3,010
0.5% 56
2021
Q1
$749K Hold
3,010
0.56% 54
2020
Q4
$692K Hold
3,010
0.55% 53
2020
Q3
$765K Hold
3,010
0.69% 40
2020
Q2
$710K Hold
3,010
0.7% 44
2020
Q1
$610K Sell
3,010
-100
-3% -$21.8K 0.72% 48
2019
Q4
$750K Buy
+3,110
New +$686K 0.73% 50

Other funds holding AMGN

Carl P. Sherr & Co's AMGN Position: Q1 2026 in Review

Carl P. Sherr & Co held its Amgen (AMGN) position steady in Q1 2026 at 3,037 shares worth $1.07M. The position accounts for 0.5% of the portfolio, ranked #43.

Carl P. Sherr & Co first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Carl P. Sherr & Co held 3,037 shares of Amgen worth $1.07M as of Q1 2026.
  • Carl P. Sherr & Co left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.5% of Carl P. Sherr & Co's portfolio in Q1 2026, its #43 holding.
  • Carl P. Sherr & Co first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Carl P. Sherr & Co's 13F filing for Q1 2026, filed 7 May 2026.